Gelteq Completes Successful Veterinary Palatability Trials

Gelteq Limited announced the successful completion of its veterinary palatability trials conducted in collaboration with Kemin Industries. The trials demonstrated that Gelteq® technology effectively masked bitter flavor profiles and improved canine acceptance of products, including those deliberately formulated with bitter compounds. This validation is crucial for veterinary pharmaceutical applications, providing insights for future product development and strengthening Gelteq's position for strategic partnerships in the animal health sector. The company believes this significantly broadens the potential range of active pharmaceutical ingredients and formulations for its proprietary gel-based delivery platform.